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Adaptations that enable antimicrobial resistance
often pose a fitness cost to the microorganism.
Resistant pathogens must therefore overcome such
fitness decreases to persist within their hosts.
Here we demonstrate that the reduced fitness
associated with one resistance-conferring mutation
can be offset by community interactions with
microorganisms harboring alternative mutations
or via interactions with the human microbiota.
Mutations that confer antibiotic resistance in the
human pathogen Staphylococcus aureus led to
decreased fitness, whereas coculture or coinfection
of two distinct mutants resulted in collective
recovery of fitness comparable to that of wild-type.
Such fitness enhancements result from the ex-
change of metabolites between distinct mutants,
leading to enhanced growth, virulence factor pro-
duction, and pathogenicity. Interspecies fitness en-
hancements were also identified, as members of
the human microbiota can promote growth of antibi-
otic-resistant S. aureus. Thus, inter- and intraspecies
community interactions offset fitness costs and
enable S. aureus to develop antibiotic resistance
without loss of virulence.
INTRODUCTION
The Gram-positive pathogen Staphylococcus aureus is one of
the most significant threats to public health and accounts for
nearly half of all deaths from antibiotic-resistant pathogens
(CDC, 2013). Multidrug-resistant S. aureus strains are prevalent
in healthcare and community settings, limiting treatment options
for life-threatening staphylococcal diseases. S. aureus resistsCell Hosantimicrobial treatment through several mechanisms, including
expression of antibiotic-modifying enzymes and efflux pumps
and accumulation of mutations that alter drug targets or cell
wall composition (Lowy, 2003). Additionally, upon exposure to
select antimicrobials, notably aminoglycosides, S. aureus and
other pathogens can adopt a respiration-deficient state known
as a small colony variant (SCV) (Proctor et al., 2006). SCVs are
isolated from chronic infections, such as osteomyelitis, and
from cystic fibrosis (CF) patients, where they are associated
with advanced pulmonary disease (Wolter et al., 2013). Human
SCV isolates commonly have mutations in the biosynthetic path-
ways for heme and menaquinone, two essential cofactors for
respiration. Because they are often deficient in respiration and
dependent on fermentation for energy, SCVs grow slowly and
are frequently resistant to many antibiotics. Yet SCVs have an
inherent fitness defect relative to wild-type due to their reduced
growth and limited virulence factor production in vitro (Proctor
et al., 2006). Therefore, themechanism by which SCVs and other
fitness-impaired, antibiotic-resistant bacteria persist and cause
disease within hosts remains elusive.
S. aureus and other pathogens are capable of growing inmulti-
cellular communities such as biofilms and microcolonies within
tissue abscesses (Cheng et al., 2011). These environments facil-
itate interbacterial communication, which may influence path-
ogen behavior. We hypothesized that the fitness cost associated
with a resistance-conferring mutation could be offset by interac-
tions between genetically distinct microorganisms in a bacterial
community. In this manuscript, we utilize coculture and coinfec-
tion strategies to demonstrate that distinct antimicrobial-resis-
tant S. aureus SCV strains utilize one another’s metabolites,
resulting in enhanced growth yields and virulence. Additionally,
our data indicate that metabolite exchange occurs at the inter-
species level, asmembers of the humanmicrobiota can promote
growth of antibiotic-resistant S. aureus. These results have
important implications for the diagnosis and treatment of antimi-
crobial-resistant infections and add to a growing body of
evidence that pathogen behavior is influenced bymicrobial com-
munity interactions.t & Microbe 16, 531–537, October 8, 2014 ª2014 Elsevier Inc. 531
Figure 1. Coculture of Genetically Distinct SCVs Results in Enhanced Growth, Virulence Factor Production, and Cytotoxicity toward
Mammalian Cells
(A) Cross-streaking of DhemB and DmenE on TSA. Arrows indicate the streak direction, and the strain applied first is denoted with an open arrow.
(B) Growth in TSB was monitored using OD600 over time. Mix indicates DhemB-DmenE coculture. DhemB* and DmenE* indicate growth with supplementation of
2 mM heme or 12.5 mM menadione, respectively. ***p < 0.05 for DhemB and DmenE relative to mix.
(C) Quorum sensing in cocultured SCVs was monitored using agr-dependent YFP expression. YFP fluorescence (relative fluorescent units [RFUs], yellow bars)
was recorded at 15 hr and normalized to OD600. ***p < 0.05. The average from three independent experiments is shown in (B) and (C). Error bars represent one SD
from the mean.
(D) SDS-PAGE of supernatants from WT, DhemB, DmenE, and mix.
(E) Immunoblot for alpha hemolysin in supernatants from the indicated strains,mix, andDhemB orDmenE supplementedwith hemeormenadione, respectively (*).
(F) Osteoblast viability after exposure to concentrated supernatant from the indicated strains. Supernatants from DhemB and DmenE were concentrated an
additional 3-fold relative to WT and the 1:1 DhemB-DmenE mix to account for differences in growth yield. Results are expressed as percent control (equivalent
volume of media). n = 10 per group, and data represent three independent experiments. ***p < 0.001 and #p < 0.001 relative toWT andmix, respectively. See also
Figures S1–S3.
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Coculture of Genetically Distinct SCVs Results in
Enhanced Growth, Virulence Factor Production, and
Cytotoxicity toward Mammalian Cells
To test the hypothesis that interactions between distinct
S. aureus strains can offset the fitness costs associated with
antimicrobial resistance, two aminoglycoside-resistant SCVs
were constructed in S. aureus by inactivating enzymes in the
biosynthetic pathways for heme (DhemB) or menaquinone
(DmenE). Both DhemB and DmenE are attenuated for growth
(Figures 1A and 1B) and exhibit increased minimum inhibitory
concentrations (MICs) to gentamicin relative to wild-type (WT
MIC = 2, DhemBMIC = 16, DmenEMIC = 12). However, growth
of DhemB and DmenE is significantly enhanced when the strains
are mixed by cross-streaking on solid media or cocultured in
broth (Figures 1A and 1B). The enhanced growth observed
upon cross-streaking of distinct SCVs is not dependent on strain
background or which heme or menaquinone biosynthetic532 Cell Host & Microbe 16, 531–537, October 8, 2014 ª2014 Elsevieenzyme is inactivated (Figures S1A–S1D, available online). The
increased growth observed with coculture of menaquinone
and heme biosynthesis mutants is, however, dependent on the
ability of the menaquinone biosynthesis mutant to synthesize
heme, as a DmenB/DhemB mutant does not enhance growth
ofDhemA orDhemB (Figures S1A and S1B). Interestingly, cocul-
ture of DhemB and DmenE failed to completely restore genta-
micin susceptibility to wild-type levels (MIC = 4 versus WT
MIC = 2), suggesting that physiologic adaptions that support
the SCV phenotype might engender bacteria with enhanced
intrinsic resistance to antimicrobials.
To further delineate the involvement of metabolite exchange in
enhanced growth of cocultured SCVs, we created a menaqui-
none-deficient strain that only synthesizes heme if provided
the precursor aminolevulinic acid (ALA) (DhemA/DmenE). Strain
DhemA/DmenE only enhances growth of the heme-deficient
SCV DhemB when ALA is supplemented in the media (Figures
S2A–S2I). This result illustrates the requirement for de novo
heme synthesis by the menaquinone-deficient strain andr Inc.
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coculture, strongly suggesting that metabolite exchange is
occurring between these two strains. Moreover, addition of the
heme-binding protein IsdI to broth culture significantly reduces
the growth of the DhemB-DmenE mixture (Figure S2J), implying
that exchange of themetabolite heme is necessary for enhanced
growth during coculture. Collectively, these results indicate that
distinct SCVs can complement each other to enhance growth
through metabolite exchange.
Increased bacterial density in DhemB-DmenE cocultures was
accompanied by enhanced activation of quorum sensing medi-
ated by the accessory gene regulator (agr) system. In contrast,
culture of DhemB or DmenE alone led to decreased activation
of quorum sensing, even after adjusting for the reduced bacterial
density of these cultures (Figure 1C; Figures S3A and S3B).
Consistent with a known role of the agr system in activation of
S. aureus virulence factor production (Novick, 2003), activation
of quorum sensing in DhemB-DmenE coculture lead to
increased protein secretion, including extracellular proteases
and the secreted toxin alpha-hemolysin (Figures 1D and 1E; Fig-
ures S3C and S3D). Activation of quorum sensing and extracel-
lular protease production have previously been demonstrated to
inversely correlate with biofilm formation (Lauderdale et al.,
2009; Mrak et al., 2012). Moreover, S. aureus SCVs are capable
of increased biofilm formation relative to wild-type (Singh et al.,
2010). We therefore assessed the functional impact of metabo-
lite exchange on biofilm formation during DhemB-DmenE cocul-
ture. Relative to either SCV alone, coculture of DhemB and
DmenE resulted in increased biofilm/biomass (optical density
580 [OD580]/OD600) ratios at early time points, likely reflecting
initial adherence. At later time points, however, DhemB-DmenE
coculture yielded lower average biofilm/biomass ratios (Figures
S3E and S3F). Finally, to investigate whether increased agr acti-
vation and secreted virulence factor production during SCV
coculture leads to increased host cell death, secreted proteins
isolated fromDhemB-DmenE coculture were incubatedwithmu-
rine osteoblasts. As compared to supernatants from wild-type,
DhemB, and DmenE, supernatants obtained from DhemB-
DmenE coculture incite significantly more osteoblast cell death
(Figure 1F). Collectively, these results demonstrate that interac-
tions between distinct SCVs enhance quorum sensing, virulence
factor production, and cytotoxicity toward mammalian cells.
Coinfection with Genetically Distinct SCVs Results in
Increased Intraosseous Bacterial Burdens and Bone
Destruction in a Murine Model of Osteomyelitis
SCVs are frequently isolated from patients suffering from osteo-
myelitis and contribute to the treatment recalcitrance of this
and other chronic infections (Proctor et al., 2006). Because
SCVs grow slowly and are deficient in virulence factor production
in vitro, it is unclear how these variants proliferate and cause tis-
sue destruction in vivo. To evaluate if interactions between
distinct SCVs enhance growth within host tissues, wild-type,
DhemB, DmenE, or a 1:1 mixture of DhemB and DmenE were
used to inoculatemice in an experimental model of osteomyelitis
(Cassat et al., 2013). Relative to wild-type, infection with either
DhemBorDmenE resulted in significantly lowerbacterial burdens
in infected femurs (Figure 2A). However, mice infected with the
DhemB-DmenE mixture sustained bacterial burdens that wereCell Hossignificantly increased by approximately two logs relative to
each SCV alone. Mice infected with the DhemB-DmenE mixture
also experienced substantially increased weight loss relative to
mice infected with either SCV alone (Figure 2B). To ascertain
the relative proportions ofDhemB andDmenESCVspresent after
in vivo coinfection, we inoculated groups of mice with a 1:1
mixture of DhemB and DmenE after in vitro growth with varying
levels of heme and menadione supplementation. Regardless of
the supplementation level prior to infection, we found that all in-
fectedmice harbored bothDhemB andDmenESCVpopulations,
with DhemB isolated at a higher frequency (Table S2). Even with
minimal or no supplementation during in vitro pregrowth, mice
infectedwith theDhemB-DmenEmixture sustained averagebac-
terial loads higher than that of either supplemented SCV alone
(Figure 2C). Bone destruction during S. aureus osteomyelitis is
dependent on production of extracellular virulence factors (Cas-
sat et al., 2013). To test if coinfection with distinct SCVs results in
increased bone destruction, groups of mice were infected with
WT, DmenE, DhemB, or DhemB-DmenE mixture, and bone
destruction was assessed 14 days later by microcomputed
tomography. Femurs from DmenE- and DhemB-infected mice
sustained drastically reduced bone destruction relative to wild-
type (Figures 2D–2H). Conversely, mice infected with the
DhemB-DmenE mixture sustained bone destruction that was
not significantly different from WT but was profoundly increased
relative to DmenE or DhemB infection. Enhanced production of
virulence factors during coculture of DhemB and DmenE there-
fore correlates with increased bone destruction in vivo. Thus,
interactions between genetically distinct staphylococci can
overcome fitness costs associated with antimicrobial resistance
to facilitate growth and virulence within mammalian hosts.
Interspecies Interactions Promote the Emergence and
Growth of Antibiotic-Resistant S. aureus
During infection, pathogensmaybe exposed tomultiple selective
pressures, including host defenses, other microorganisms, and
antimicrobial compounds. In CF patients whose lungs are in-
fected by S. aureus, staphylococci are not only exposed to anti-
biotics such as aminoglycosides, but also frequently encounter
other bacterial pathogens such as Pseudomonas aeruginosa
(Hubert et al., 2013; Schneider et al., 2008). During coinfection,
P. aeruginosa secretes the exotoxin pyocyanin, which hinders
S. aureus respiration (Hoffman et al., 2006; Voggu et al., 2006).
In response to this pressure, S. aureus can grow as an SCV,
rendering it resistant to pyocyanin (Biswas et al., 2009). We hy-
pothesized that pyocyanin-induced SCVsmight enhance growth
of aminoglycoside-induced SCVs during coculture. SCVs were
generatedbyexposureofS. aureus to either gentamicin (SCVgent)
or pyocyanin (SCVpyo). Both SCVs exhibited elevated MICs to
gentamicin (SCVgent = 24; SCVpyo = 48). SCVpyo exhibited an
enhanced growth rate onmenadione-supplementedmedia, sug-
gesting that it is amenadione auxotroph. Conversely, SCVgent did
not display enhanced growth after supplementation with mena-
dione, heme, or thymidine, suggesting one or more alternative
auxotrophies (data not shown). Coculture of SCVgent with SCVpyo
results in enhancedgrowth (Figures 3Aand3B).Moreover, cocul-
ture of SCVgent with SCVpyo increases growth over each single
SCV even in the presence of gentamicin (Figure 3C). Accordingly,
the gentamicinMIC ofmixed SCVgent-SCVpyo culture was 16.Wet & Microbe 16, 531–537, October 8, 2014 ª2014 Elsevier Inc. 533
Figure 2. Coinfection with Genetically Distinct SCVs Results in Increased Intraosseous Bacterial Burdens and Bone Destruction in a Murine
Model of Osteomyelitis
(A) Groups of mice were subject to osteomyelitis by inoculation of the indicated strains following in vitro growth in 2 mM heme (DhemB) or 12.5 mM menadione
(DmenE). Bacterial burdens were determined after 7 days. Horizontal bar represents the mean. **p < 0.01, ***p < 0.001. n = 5 mice per group.
(B) Percent initial weight was calculated daily for mice infected in (A).
(C) The same as in (A) except that strainswere grown in vitro inminimal (0.25 mMheme and 5 mMmenadione) or no supplementation prior tomixing and inoculation.
(D) Quantification of cortical bone destruction. n = 5 mice per group. Error bars represent SEM. *p < 0.05, ***p < 0.001 relative to both WT and mix. N.S., not
significant.
(E–H) Representative microcomputed tomography images of femurs infected withWT (E), DmenE (F), DhemB (G), and DhemB-DmenEmix (H). Three femurs with
median bone loss are shown for each group. See also Table S2.
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tested SCVs generated by exposure to gentamicin. Collectively,
these data reveal that staphylococcal SCVs induced by distinct
selective pressures can interact to overcome the fitness defect
associated with respiration arrest.
To test if interspecies interactions that are not antagonistic can
also promote the growth of antibiotic-resistant pathogens, the
ability of Enterococcus faecalis to enhance the growth of
S. aureus SCVs was determined. Enterococci are frequently iso-
lated with staphylococci in diabetic soft tissue infections (Citron
et al., 2007). Cross-streaking of E. faecalis with S. aureus SCVs
inactivated for menaquinone biosynthesis results in enhanced
growth. This process is dependent on heme synthesis by
S. aureus, as E. faecalis cannot synthesize heme and therefore
does not enhance growth of DhemB. In total, these findings
imply that the growth enhancement requires either heme534 Cell Host & Microbe 16, 531–537, October 8, 2014 ª2014 Elsevieexchange from S. aureus, menaquinone exchange from
E. faecalis, or both (Figure S4) (Whittenbury, 1964).
Coculture of Distinct, Antimicrobial-Resistant SCVs
Isolated from CF Patients Enhances Growth
Previous studies utilizing in vitro assays and animal models have
demonstrated that both intra- and interspecies bacterial interac-
tions can elicit changes in bacterial physiology and virulence.
However, there is a paucity of data to implicate such interactions
in the virulence of antibiotic-resistant bacterial pathogens in vivo
in humans. To investigate if distinct, slowly growing microorgan-
isms from humans can enhance one another’s growth, we iso-
lated and archived bacteria from the respiratory tract of CF
patients. Within these samples, we identified members of the
human upper respiratory microbiota, including S. epidermidis,
Streptococcal species, and diphtheroid-like organisms that arer Inc.
Figure 3. Pyocyanin-Resistant SCVs Enhance the Growth of Antimi-
crobial-Resistant SCVs
(A) SCVgent and SCVpyo cross-streaking on TSA.
(B) Growth of WT, SCVgent, SCVpyo, and SCVgent-SCVpyo mix in TSB was
monitored using OD600 over time.
(C) Growth of the indicated strains in TSB containing various concentrations of
gentamicin was monitored using OD600 after 8 hr. The average from three in-
dependent experiments is shown. Error bars represent one SD from the mean.
See also Figure S4.
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both (Figure 4A). Furthermore, we isolated distinct, gentamicin-
resistant S. aureus SCVs from the same patient and discovered
that a subset of these SCVs could enhance growth of laboratory-
derived SCVs (Figures 4B and 4C) as well as one another (Fig-
ure 4D) during coculture. These data suggest that metabolite
exchange may also occur within human microbial communities
to enhance growth of antibiotic-resistant bacteria.
DISCUSSION
In this report, we demonstrate that distinct S. aureus strains can
interact in vitro and in vivo with one another and with the human
microbiota to overcome the fitness cost associated with antimi-
crobial resistance mutations. Enhancement of growth and viru-
lence is dependent on the mutual production and procurement
of specific metabolites by distinct mutants and allows groups
of fitness-impaired, antibiotic-resistant S. aureus to achieve a
collective fitness comparable to wild-type. Our results strongly
suggest that the mechanism of growth enhancement in SCV
coculture is exchange of metabolites. However, the precise
mechanism by which thesemetabolites exit the cell, are incorpo-
rated into the recipient cell, and are ultimately utilized for cellular
processes remains to be determined. After in vivo coinfection
with heme- and menadione-deficient SCVs, we found a predom-
inance of heme-deficient mutants. This may reflect the relative
efficiency of heme exchange as compared to menadione. Alter-
natively, these results may reflect the presence of dedicated
heme acquisition systems in S. aureus or the increased bioavail-Cell Hosability of host heme as compared to menadione. Nevertheless,
these experiments were performed in the absence of antibiotic
selection, which we predicted would lead to an iterative process
whereby multiple antibiotic-resistant mutants are generated dur-
ing thecourse of infection, a subset ofwhich could then interact to
enhance growth and virulence. Our data have significant implica-
tions for the diagnosis and treatment of chronic infections caused
by SCVs. Current diagnostic practices may be inadequate, as a
single antibiotic resistance profile is often interpreted as evidence
of clonality in clinical specimens, yet our data suggest that such
samples may contain genetically distinct bacterial populations
whose interactions can alter antimicrobial resistance and viru-
lence properties. Concerning treatment, these data suggest that
fitness costs associated with antimicrobial resistance, and spe-
cifically the S. aureus SCV phenotype, can be overcome in vivo
to promote virulence. Diversity within a bacterial community,
both at the strain and species level, therefore affords S. aureus
the ability to tolerate fitness-reducing mutations that promote
persistence in their host while maintaining virulence potential.
EXPERIMENTAL PROCEDURES
Ethics Statement
All experiments involving animals were reviewed and approved by the Institu-
tional Animal Care and Use Committee of Vanderbilt University and performed
according to NIH guidelines, the Animal Welfare Act, and US Federal law.
Human clinical samples were obtained under a protocol approved by the
Vanderbilt Institutional Review Board.
Bacterial Strains and Growth Conditions
Unless otherwise noted, all experiments utilized derivatives of the S. aureus
strain JE2 (WT) (Fey et al., 2013). Bacteria were grown on tryptic soy broth
(TSB) solidified with 1.5% agar (TSA) at 37C or in TSB with shaking at
180 rpm, unless otherwise indicated. TSB was supplemented with 10 mg/ml
erythromycin where indicated. Aminolevulinic acid (ALA) was supplemented
to solid growth media at a final concentration of 75 mg/ml and onto sterile
Whatman paper discs at a concentration of 50 mg/ml. IsdI was purified from
Escherichia coli BL21 (DE3) as previously described (Skaar et al., 2004).
Bacterial strains and plasmids used in this study are listed in Table S1. Phage
F85-mediated transduction of the hemB and menE erythromycin cassette-
disrupted allele was used to transfer these insertion mutations from
S. aureus Newman to JE2. Gentamicin MICs were determined using Etest
strips (Biomerieux) according to manufacturer’s instructions. Quorum sensing
was monitored during growth of S. aureus using the fluorescent reporter
plasmid pDB59 (agr-P3-YFP) (Malone et al., 2009; Yarwood et al., 2004). Bac-
terial cultures were diluted 1:100 from overnight culture, and optical density
was measured as absorbance at 600 nm. YFP fluorescence was monitored
using a BioTek plate reader with excitation and emission filters of 485 nm
and 525 nm, respectively. Differences in growth yields and YFP fluorescence
between strains were analyzed by Student’s t test. Strain SCVgent was created
by inoculating WT S. aureus into TSB containing 10 mg/ml gentamicin and
growing at 37C for 8 hr. The resulting culture was plated at limiting dilution
onto TSA and grown overnight at 37C. Isolated SCVswere passaged 10 times
on TSA and then plated onto TSA containing 10 mg/ml gentamicin to ensure
stability of the SCV phenotype and gentamicin resistance. Strain SCVpyo
was created by plating S. aureus Newman on plates containing 20 mg/ml of
pyocyanin and selecting a resultant SCV. The auxotrophy of SCVgent and
SCVpyo was tested by plating either strain on TSA supplemented with 2 mM
heme, 5 mM menadione, or 25 mM thymidine.
Isolation of Slowly Growing Microorganisms from Cystic Fibrosis
Patients
Bronchoalveolar lavage (BAL) fluid and sputum samples were obtained from
adult and pediatric patients with cystic fibrosis at Vanderbilt UniversityMedical
Center. Samples were deidentified of all personally identifying information byt & Microbe 16, 531–537, October 8, 2014 ª2014 Elsevier Inc. 535
Figure 4. Coculture of Distinct, Antimicrobial-Resistant SCVs Isolated from CF Patients Enhances Growth
(A) Slowly growing bacterial colonies were isolated and archived from the sputa of adult and pediatric patients suffering from CF at Vanderbilt University Medical
Center. Polymicrobial samples were labeled successively as VUCF001, VUCF002, etc. Individual, slowly growing bacterial colonies were isolated from each
sample and archived as VUCF001.1, VUCF001.2, etc. Individual small colonies were then cocultured with DhemB or DmenE on solid media to assess for
enhanced growth. A representative subset of isolated SCVs is shown.
(B and C) Isolated, gentamicin-resistant S. aureus SCVs from a single patient were cocultured with DhemB (B) or DmenE (C) on solid media to assess for
enhancement of growth.
(D) Select gentamicin-resistant S. aureus were cocultured with each other on solid media to demonstrate growth enhancement. A representative subset of
growth-enhancing pairs is shown. Strain identities are as follows: VUCF001.1, Staphylococcus epidermidis; VUCF001.2 and VUCF001.3, diphtheroid-like Gram-
positive rods; VUCF002.1, Streptococcus sobrinus; VUCF003.1–VUCF003.5, S. aureus.
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microbiologic analysis. BAL fluid or sputum samples were serially diluted in
sterile PBS and plated onto TSA. Freezer stocks of the entire bacterial
population from each patient sample were created by removing bacterial
growth from the TSA plates and resuspending in a solution of 5% BSA and
5% L-glutamic acid sodium salt. Slowly growing bacterial colonies were
subsequently identified from patient samples after 48–72 hr of growth on
TSA at 37C. Individual small colonies were passaged on TSA to ensure
maintenance of the small colony phenotype and then cocultured with other
small colonies in the patient sample or with DhemB and DmenE by cross-
streaking. To identify gentamicin-resistant small colonies, archived bacterial
populations from each patient sample were plated onto TSA supplemented
with 6 mg/ml gentamicin. Gentamicin-resistant small colonies were then
passaged on TSA as above before coculture with other small colonies in
the patient sample or with DhemB and DmenE. Freezer stocks of individual
small colonies were also created as above. Species identification of
slowly growing microorganisms was accomplished by a combination of
Gram stain, catalase testing, Staphaurex agglutination assay, as well as auto-
mated identification on a Becton Dickinson Phoenix Automated Microbiology
System.
Preparation of S. aureus Culture Supernatant
To prepare concentrated culture supernatants, 24 hr (DhemB and DmenE) or
12 hr (WT) TSB cultures were back-diluted 1:100 into 50 ml RPMI supple-
mented with 1% casamino acids in a 250 ml flask. A 1:1 DhemB-DmenE mix
RPMI culture was inoculated using a 1:200 dilution of DhemB TSB culture
and a 1:200 dilution of DmenE TSB culture. RPMI cultures were grown for
15 hr at 37C and 180 rpm shaking, after which time supernatants were
collected by centrifugation. Supernatants were then filtered through a
0.22 mm filter and concentrated with Amicon Ultra 3 kDa nominal molecular
weight limit centrifugal filter units (Millipore). Supernatants from DhemB and
DmenE were concentrated an additional 3-fold relative to WT and the 1:1
DhemB-DmenE mix to account for differences in growth yield. Secreted pro-
teins in culture supernatants were resolved by SDS-PAGE after addition of
an equivalent volume of 23 SDS buffer and heating to 95C. Gels were subse-
quently stained with Protein Assay Dye Reagent (Bio-Rad). Alternatively, the
resolved proteins were transferred to a nitrocellulose membrane and sub-
jected to immunoblot using a mouse monoclonal anti-Hla antibody (Sigma).
An Alexa Fluor-conjugated secondary antibody was used for visualization
(Life Sciences).536 Cell Host & Microbe 16, 531–537, October 8, 2014 ª2014 ElsevieOsteoblast Cytotoxicity Assays
MC3T3-E1 subclone 4 cells were obtained from the American Type Culture
Collection (ATCC) and propagated according to ATCC recommendations.
Cells were grown at 37C and 5% CO2 with replacement of media every 2 or
3 days. Osteoblast cytotoxicity assays were then performed as previously re-
ported (Cassat et al., 2013). Differences in cell viability after exposure to
various supernatants were analyzed by Student’s t test.
Biofilm Assay
Cultures of WT, DhemB, and DmenE were grown overnight in TSB supple-
mented with 3% NaCl and 0.5% glucose. Biofilms were grown in plasma-
coated 96-well plates with duplicate rows by inoculating TSB with 3% NaCl
and 0.5% glucose with a 1:50 ratio of WT, DhemB, DmenE, and a mix of equal
volumes ofDhemB and DmenE. Biofilms were incubated statically at 37C and
processed every 2 hr for 12 hr, then every 12 hr for 3 days. To account for dif-
ferences in growth rate among strains, the biofilm data are expressed as a ratio
of crystal violet staining (OD580) to biomass (OD600), and statistical significance
was determined by Student’s t test. Biomass of each strain was determined in
duplicate wells by mechanically disrupting the biofilm with a pipette tip and
vigorous pipetting, followed by resuspension of the disrupted biofilm with
the planktonic growth and reading the optical density at 600 nm (OD600). Crys-
tal violet staining for biofilm formation was performed as follows: biofilms were
washed three times with PBS, fixed with 100% ethanol, and then stained with
crystal violet before washing an additional three times with PBS. Biofilms were
destained with 33% acetic acid, and the crystal violet stain was read at an
optical density at 580 nm (OD580).
Murine Model of Osteomyelitis and Microcomputed Tomography
Osteomyelitis was induced in 6- to 8-week old female C57BL/6J mice as
previously reported (Cassat et al., 2013). For experiments to enumerate bac-
terial burdens from infected femurs, strains DhemB and DmenE were grown
in TSB supplemented with 2 mM heme or 12.5 mM menadione, respectively,
to ensure that all strains were respiration proficient at inoculation and that
in vivo proliferation would not be influenced by in vitro growth rates. For exper-
iments to calculate bone destruction in infected femurs, strains DhemB and
DmenE were grown in TSB supplemented with 0.25 mM heme or 5 mM mena-
dione to provide the minimum amount of supplementation to support in vitro
growth rates approximately equivalent to WT. For experiments to enumerate
the proportions of DhemB and DmenE SCVs present in infected femurs
after in vivo coinfection, groups of five mice were infected with a 1:1 mixturer Inc.
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12.5 mM menadione), minimal supplementation (0.25 mM heme, 5 mM mena-
dione), or no supplementation. Prior to inoculation, bacteria were collected
by centrifugation, washed with PBS, and resuspended to a concentration of
13 106 colony forming units (cfu) in 2 ml PBS. Importantly, DhemB and DmenE
were not mixed until the moment of inoculation to ensure that there was no
in vitro growth enhancement prior to infection. Infection was allowed to pro-
ceed for 7 or 14 days, at which time mice were euthanized and the left femur
was removed and either processed for cfu enumeration or imaged bymicroCT.
For CFU enumeration, femurs were homogenized and plated on TSA, TSAwith
2 mMheme, or TSAwith 5 mMmenadione to determine the total number of bac-
teria present and the number of DhemB and DmenEmutants present, respec-
tively. A minimum of 50 colonies were counted in duplicate when determining
the proportion of DhemB and DmenE mutants in infected femurs. Differences
in mean bacterial burdens from groups of mice were analyzed using Student’s
t test.
Analysis of cortical bone destruction was determined by microCT imaging
as previously described (Cassat et al., 2013). Differences in cortical bone
destruction and peripheral new bone formation were analyzed using Student’s
t test.
Statistical Analyses
Data were analyzed by two-tailed Student’s t test using GraphPad Prism soft-
ware. Significance was defined as p% 0.05.
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